MUC1 and tumor：signaling pathways and clinical research

Yi Shouhui; Nian Weiqi; Wu Zhijuan; Yang Wenying; Chen Xiaopin; Zhao Qicheng; Wang Donglin

您当前的位置：

首页 >

文章列表页 >

MUC1 and tumor：signaling pathways and clinical research

更新时间：2023-12-18

- MUC1 and tumor：signaling pathways and clinical research
- Journal of Chongqing Medical University Vol. 40, Issue 8, Pages: 1059-1064(2015)
- 作者机构：
  
  1. 重庆市肿瘤医院肿瘤科,重庆,400011
  2. 重庆医科大学附属第一医院肿瘤科,重庆,400010
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2015，
扫描看全文
Yi Shouhui, Nian Weiqi, Wu Zhijuan, et al. MUC1 and tumor：signaling pathways and clinical research. [J]. Journal of Chongqing Medical University 40(8):1059-1064(2015)
DOI：

Yi Shouhui, Nian Weiqi, Wu Zhijuan, et al. MUC1 and tumor：signaling pathways and clinical research. [J]. Journal of Chongqing Medical University 40(8):1059-1064(2015) DOI：

摘要

MUC1是一种异源二聚体跨膜糖蛋白，由氮端亚单位（MUC1-N）和碳端亚单位（MUC1-C）组成。MUC1在多种上皮来源的肿瘤组织中异常表达，其与肿瘤的发生发展密切相关。MUC1-N可与细胞间黏附分子-1、E-选择素和半乳凝素-3相互作用并且通过MUC1-C调节信号传导，MUC1-C可与表皮生长因子受体家族和其他酪氨酸激酶受体相互作用并且参与PI3K→AKT、MAP、NF-κB、Wnt、STAT、P53和Erα信号通路，因此MUC1与肿瘤的增殖、侵袭转移和化疗耐药密切相关。本研究阐述了MUC1-N和MUC1-C与其他分子相互作用以及在激活肿瘤相关信号通路中的作用，最后回顾了MUC1-N单抗、MUC1-C小分子肽和MUC1疫苗在临床试验阶段的研究情况。

Abstract

MUC1 is a heterodimeric transmembrane glycoprotein formed by two subunits（N terminal and C terminal）. MUC1 is aber－rantly overexpressed in the epithelium originated tumor and is closely related to tumor development. MUC1-N interacts with ICAM-1，E-selectin and Galectin-3 and mediates signal transduction through MUC1-C；MUC1-C interacts with ErbB and other receptor tyro－sine kinases and engages in the PI3K→AKT，MAP，NF-κB，Wnt，STAT，P53 and Erα pathways，resulting in tumor proliferation，inva－sion and migration and chemoresistance. We review the role of MUC1-N and MUC1-C in interacting with other molecules and acti－vating signaling pathways. Finally，we review the clinical trials of the therapies of MUC1-N monoclonal antibodies，MUC1-C small molecule peptides and MUC1 vaccines.

关键词

MUC1-NMUC1-C肿瘤信号通路靶向治疗

Keywords

MUC1-NMUC1-Ctumorsignaling pathwaystargeted therapy

references

Views

1388

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Advances in and reflections on bacteria-mediated oncology therapy

Advances in metabolic enzymes in the hexosamine biosynthetic pathway and OGT-mediated O-GlcNAc modification in tumors

Advances in antibody-drug conjugate in the treatment of urothelial carcinoma

Masses in maxillofacial region of 859 children:a retrospective analysis

In vivo imaging and preliminary treatment experiments of docetaxel-loaded ultrasound microbubbles decorated with TATp and SDF-1 agents

Related Author

Zining Wang

Ying Zhu

Yang Luo

Wei Gu

Yang Jiayao

Tang Ni

Wang Kai

Bai Xuesong

Related Institution

Center for Intelligent Testing and Molecular Medicine， School of Medicine， Chongqing University

Key Laboratory of Molecular Biology of Infectious Diseases，Ministry of Education，Chongqing Medical University

Department of Urology，The First Affiliated Hospital of Chongqing Medical University

Department of Stomatology,the Children’s Hospital,Chongqing Medical University

Key Laboratory for Oral Biomedical Engineering in Chongqing

⁰